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OVERLINE: PARASITIC INFECTIONS 
One Sentence Summary: Mass cytometry identifies clusters of type 2 and regulatory immune 
responses in pre and post anthelmintic treatment human blood samples.  
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Editor’s summary: Parasite perturbation of immunity 
Helminths infect billions of people and are known to modulate host immune responses to 
promote their survival. De Ruiter et al. used mass cytometry to gain a better understanding of 
which cells are affected by helminth infection. They analyzed samples from Europeans or urban 
Indonesians, neither of which had been exposed to helminths. These were compared to samples 
from rural Indonesians before and after deworming treatment. Helminths expanded innate 
lymphoid type 2 cells, T helper type 2 cells, a subset of regulatory T cells, and IL-10 producing 
B cells. The immune alterations resolved upon deworming. These details on host-pathogen 
interaction could inform future targeted therapies. 
 
Abstract  
 
Helminth infections induce strong type 2 and regulatory responses, but the degree of heterogeneity 
of such cells is not well characterized. Using mass cytometry we profiled these cells in Europeans 
and Indonesians not exposed to helminths, and in Indonesians residing in rural areas, infected with 
soil-transmitted helminths. To assign immune alteration to helminth infection, the profiling was 
performed before and 1 year after deworming. Very distinct signatures were found in Europeans 
and Indonesians, showing expanded frequencies of Th2 cells, in particular CD161+ cells, and 
ILC2s, in helminth-infected Indonesians, which was confirmed functionally through analysis of 
cytokine-producing cells. Besides ILC2s and CD4+ T cells, CD8+ T cells and γδ T cells in 
Indonesians produced type 2 cytokines. Regulatory T cells were also expanded in Indonesians, but 
only those expressing CTLA-4, and some co-expressed CD38, HLA-DR, ICOS, or CD161. 
CD11c+ B cells were found to be the main IL-10 producers among B cells in Indonesians, a subset 
which was almost absent in Europeans. A number of the distinct immune profiles were driven by 
helminths as the profiles reverted following clearance of helminth infections. Moreover, 
Indonesians with no helminth infections residing in an urban area showed immune profiles that 
resembled Europeans rather than rural Indonesians, which excludes a major role for ethnicity. 
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Detailed insight into the human type 2 and regulatory networks could provide opportunities to 
target these cells for more precise interventions.  
 
Introduction 
 
There are considerable population differences in immune profiles (1, 2), which, although in part 
can be explained by genetic factors, seems to be largely driven by environmental exposures (3, 4). 
One such exposure is to helminths, which are ubiquitous in many parts of the world (5). Such 
parasites are known as the strongest natural inducers of type 2 immune responses (6) characterized 
by CD4+ T helper 2 (Th2) cells secreting the hallmark cytokines interleukin (IL)-4, IL-5 and IL-
13, as well as group 2 innate lymphoid cells (ILC2s), which are the predominant innate source of 
type 2 cytokines. Although ILC2s have been studied extensively in mice (7-9), it has been 
challenging to study these cells in humans due to their low frequency in peripheral blood (10). 
Together, these type 2 immune responses lead to eosinophilia, expansion of basophils and mast 
cells, goblet cell hyperplasia, and the production of IgE (11). There is evidence for a role of type 
2 immune responses in controlling helminth parasites through killing or expulsion, and in inducing 
tissue repair, necessary to protect against damage caused by tissue-migrating helminths (12). 
However, there is increasing realization that type 2 cells might participate in maintaining 
physiological homeostasis, for example glucose metabolism or thermoregulation (13). It is also 
known that these cells can play a pathological role, for example in allergic diseases, such as asthma 
(14).  
Besides polarizing the immune system towards a type 2 immune response, helminths can 
induce a strong regulatory network (15-18), which can enhance their survival within their host but 
at the same time affect responses to bystander antigens, such as allergens, autoantigens, or vaccines 
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(19). Regulatory T cells (Tregs), expressing FOXP3, are an important component of such a 
network, and mediate their effects through suppressive cytokines (e.g. IL-10 and TGF-β) and/or 
via the expression of suppressor molecules such as cytotoxic T lymphocyte antigen 4 (CTLA-4) 
(20). Although longitudinal studies assessing the effect of deworming on Tregs are rare, we 
recently found that not the Treg frequencies, but the expression of CTLA-4 on CD4+ T cells 
significantly declined in anthelmintic-treated individuals (21).  
Given the spectrum of immune modulatory effects that helminths exhibit, we believe that 
by understanding type 2 and regulatory responses in depth it will be possible to devise 
interventions that could help vaccine responses or curtail inflammation that damages tissues and 
organs in a more targeted manner.  
With the advent of mass cytometry, it has become possible to capture the complex profile 
of immune cells (22). To better understand the helminth-modulated responses and identify cell 
populations that might be closely linked to this process, we performed immune profiling by mass 
cytometry with an emphasis on type 2 and regulatory responses, using simultaneous measurement 
of 37 cellular markers at the single-cell level to allow high-resolution dissection of the cellular 
composition. A well-established technique for mass cytometry data analysis is t-distributed 
Stochastic Neighbor Embedding (t-SNE) (23), which allows visualization of all concurrent marker 
expression profiles of cells on a two-dimensional plot in an unbiased fashion. However, t-SNE 
does not scale well to large amounts of data. Recently introduced techniques, such as Uniform 
Manifold Approximation and Projection (UMAP) (24) and Hierarchical Stochastic Neighbor 
Embedding (HSNE) (25) promise to overcome this scaling problem. Here, we applied HSNE, as 
implemented in Cytosplore (26), to visualize and cluster the data. These methods were applied to 
study type 2 and regulatory responses ex vivo, in addition to determining function in terms of 
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cytokine production in Europeans and helminth-infected Indonesians, before and one year after 3-
monthly anthelmintic treatment, when they became free of helminth infection.  
 
Results  
 
Distinct immune signatures between Europeans and rural Indonesians 
The first study cohort consisted of age- and sex-matched Europeans without prior exposure to 
helminths and Indonesians from a rural area, infected with soil-transmitted helminths before and 
after 1 year of deworming (table S1 and table S2). The 37-metal isotope-tagged monoclonal 
antibody panel (table S3) allowed the identification of six major immune lineages (CD4+, CD8+, 
γδ T cells, B cells, myeloid cells, and innate lymphoid cells (ILCs; CD3-CD7+)), and major 
subpopulations and detailed cell clusters within. Importantly, by using the t-SNE-based HSNE 
(26), we could explore the full mass cytometry dataset containing 20.3 million live CD45+ cells at 
the single-cell level without the need for downsampling. At the overview level, landmarks 
(representative cells) depict the global composition of the entire immune system and distinguish 
the major immune lineages, which were annotated based on lineage marker expression overlays 
(Fig. 1A-B). Quantification of cell frequencies revealed a significantly higher frequency of B cells 
in Indonesians (P < 0.05), but no other differences were found between Europeans and Indonesians 
at the lineage level (Fig. 1C, fig. S1). Next, CD4+ T cell landmarks, representing 6.3 million cells, 
were selected at the overview level and a new higher resolution embedding was generated at the 
second level of the hierarchy (Fig. 1D), revealing subpopulations within the CD4+ T cell lineage 
(Fig. 1D). Stratification by origin of the samples revealed a strikingly different distribution of the 
CD4+ T cells between Europeans and Indonesians, visualized by cell density plots (Fig. 1E). 
Different cellular distributions were also observed within other lineages (CD8+, γδ T cells, B cells, 
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myeloid cells and ILCs) (Fig. 1E), suggesting very distinct immune signatures between Europeans 
and rural Indonesians in both the innate and adaptive immune compartment. 
 
A CD161+ subpopulation of Th2 cells is expanded in rural Indonesians and decreases after 
anthelmintic treatment  
Within the CD4+ T cells, a distinct population of Th2 cells was found that expressed GATA3, 
CD25, CD127, CD45RO and chemoattractant receptor-homologous molecule expressed on Th2 
(CRTH2), the latter being the most reliable marker to identify human Th2 cells (27) (Fig. 2A). The 
frequency of total Th2 cells was higher in rural Indonesians compared to Europeans and 
importantly, deworming resulted in a decrease (Fig. 2B). This is in line with the observation that 
the proportion of circulating eosinophils as well as serum levels of total IgE, both markers of the 
type 2 response, significantly decreased in the helminth-infected Indonesians after treatment (Fig. 
S2, P < 0.01). 
Further analysis of Th2 cells revealed 22 phenotypically distinct clusters using the 
Gaussian mean shift (GMS) clustering (Fig. 2C).  Th2 cells showed considerable heterogeneity 
and based on the expression of the lectin-like receptor CD161 and CD27, the latter which is lost 
on highly differentiated memory CD4+ T cells (28, 29), three subpopulations could be identified 
(CD161+CD27-, CD161-CD27- and CD161-CD27+ Th2 cells; Fig. 2C-D). Visualization of Th2 
cells by density plots (Fig. 2E) showed that the proportion of CD161+ Th2 cells may have been 
expanded in rural Indonesians compared to Europeans, although the difference fell short of 
statistical significance, but a decrease was observed after anthelmintic treatment (Fig. 2F). Deeper 
analysis at the cluster level revealed three clusters within the CD161+ Th2 population that declined 
upon deworming (Fig. 2G). These clusters were not only reciprocally expressing CD7 and KLRG1 
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(CD161+CD7-KLRG1+ and CD161+CD7+KLRG1-), but also contained cells that did not express 
CD7 or KLRG1 (Fig. 2G), suggesting that helminth infection not only expanded effector cells in 
a more terminally differentiated state (30) but also CD161+ cells in transition . In contrast, after 
one year of treatment we observed an increase of three CD7+ Th2 clusters that only weakly 
expressed GATA3 and CRTH2 (Fig. 2G), suggesting an expansion of cells with lower type 2 
cytokine production (31, 32). 
The proportion of poorly differentiated CD27+ Th2 cells was higher in Europeans (Fig. 2F) 
and this difference was specifically in the CCR7- cluster within the CD27+ Th2 cell subpopulation 
(Fig. 2G). This finding indicates that in contrast to rural Indonesians, the frequency of highly 
differentiated memory effector Th2 cells in the immune system of Europeans is low.  
 
Overall frequency of ILC2s is expanded in rural Indonesians but does not decrease after 
anthelmintic treatment 
The study of human helper-like ILCs has been difficult due to their low frequency in peripheral 
blood. However, using mass cytometry, it was possible to analyze these cells at a detailed level as 
part of 2.8 million ILCs (CD3-CD7+), which include NK cells as well (Fig. 3A). The embedding 
of a CD25+CD127+CD161+ subpopulation revealed 2 distinct clusters that were phenotyped as 
ILC2s and ILC3s, based on the expression of CRTH2 and c-Kit, respectively (Fig. 3A). It was 
found that other markers such as GATA3, KLRG1, CD45RA, and CCR6 could also be expressed 
by ILC2s and/or ILC3s (Fig. 3A). Consistent with previous work (33), we observed that whereas 
GATA3, the Th2 master transcription factor, was highly expressed in CRTH2+ ILC2s, it was also 
expressed in CRTH2- ILCs and can therefore not exclusively be used to define ILC2s. In contrast 
to ILC3s, the proportion of ILC2s was higher in rural Indonesians compared to Europeans, but did 
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not decrease after anthelmintic treatment (Fig. 3B). Further characterization of ILC2s resulted in 
8 phenotypically distinct clusters that could be distinguished by the expression of CD45RA, 
KLRG1, and CCR6 (Fig. 3C), showing more heterogeneity than what has been described so far 
based on the varying expression of KLRG1 and CCR6 on ILC2s (34). Moreover, the expression 
of CCR6, involved in gut homing (35), has been seen on peripheral blood ILC2s in patients with 
inflamed tissues (36). Interestingly we observe a lower frequency of KLRG1+CCR6+ ILC2s 
(cluster 5) in Indonesians infected with helminths residing in the GI tract, compared to Europeans 
(Fig. 3D).  
 
Helminth infections increase the expression of inhibitory molecules on Tregs 
Tregs characterized as FOXP3+CD25highCD127low cells appeared as a clearly distinct 
subpopulation within CD4+ T cells (Fig. 4A). The frequency of Tregs, when assessed as a whole, 
did not differ between Europeans and Indonesians, nor changed after deworming (Fig. 4B). 
However, the immune profile of rural Indonesians consisted of more effector Tregs expressing 
CD45RO (Fig. 4C), whereas in Europeans, a clear population of Tregs was positioned in the naïve, 
CD45RA+, compartment (Fig. 4D). In line with previous studies describing Tregs as 
phenotypically and functionally heterogeneous (20), we found several subpopulations within the 
effector Treg compartment expressing CTLA-4, HLA-DR, CD38, and/or ICOS (Fig. 4E). A 
substantial proportion of the effector Tregs expressed CTLA-4, a marker that is associated with 
the suppressive function of Tregs (37). In concordance with this, the proportion of CTLA-4+ Tregs 
was higher in rural Indonesians compared to Europeans and decreased after anthelmintic treatment 
(Fig. 4F). 
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Next, we identified 27 phenotypically distinct clusters within Tregs (Fig. 4G-H). Analysis at 
the cluster level revealed that the frequencies of 6 out of 27 clusters were higher in rural 
Indonesians compared to Europeans, distinguished by the expression of only CTLA-4, or co-
expression of CD38 and/or HLA-DR and/or ICOS (Fig. 4H). One of these clusters (cluster 7) 
expressing CTLA-4, HLA-DR, CD38, and ICOS, decreased upon deworming, suggesting that this 
population of effector Tregs is particularly important in the immune response induced by helminths 
. Of note, among the CTLA-4+ Tregs, we identified a cluster expressing CD161 (cluster 25; Fig. 
4H). CD161+ Tregs were recently described as a highly suppressive, cytokine-producing 
population of Tregs that was enriched in the intestinal mucosa, particularly in inflammatory bowel 
disease, where they can enhance wound repair (38). The proportion of CD161+ Tregs was higher 
in rural Indonesians compared to Europeans but did not change after deworming (Fig. 4I), 
suggesting that factors other than helminth infections might be associated with the presence of 
such cells. 
 
Type 2 cytokine-producing cells in rural Indonesians (ILC2s, CD4+, CD8+ and γδ T cells) 
and their alteration after deworming 
Following the phenotypic characterization of type 2 cells, the cytokine production of 
PMA/ionomycin-stimulated cells was analyzed through a second CyTOF panel (Table S4) which 
included IFNγ, TNFα, IL-2, IL-17, IL-10 and IL-4/IL-5/IL-13 (simultaneously assessed and 
hereafter referred to as ‘type 2 cytokines’), to assess their functional capacity. Type 2 cytokine-
producing CD45+ cells were analyzed in Cytosplore and clustering on surface markers revealed 
striking differences between Europeans and helminth-infected Indonesians (Fig. 5A-C). Overall 
four distinct type 2 cytokine-producing subpopulations were identified (Fig. 5D, Fig. S3) of which 
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CD4+ T cells and ILC2s showed the greatest per-cell type 2 cytokine expression (Fig. 5E).Whereas 
the CD25- proportion of CD4+ and CD8+ T cells and all γδ T cells co-expressed IFNγ with the type 
2 cytokines, ILC2s did not (Fig. 5E-F). Helminth-infected rural Indonesians exhibited a higher 
frequency of total type 2 cytokine-producing cells compared to Europeans and this trend was 
consistently observed for the individual subpopulations (Fig. 5G-H), suggesting that helminths 
expand the cellular sources for these cytokines. Importantly, the proportion of type 2 cytokine-
producing cells declined after deworming (Fig. 5G) and this was attributed to a decrease in type 2 
cytokine-producing CD4+ T, CD8+ T cells and ILC2s (Fig. 5H). 
The proportion of type 2 cytokine-producing CD8+ T cells correlated strongly with a subset 
previously defined as type 2 cytotoxic T (Tc2) cells (39, 40) (r=0.87, P < .001), which were 
phenotypically identified as a GATA3+ cluster within a subpopulation of CD45RO+CCR7-CD161-
CD56- CD8+ T cells (2.1% of CD8+ T cells), expressing CRTH2, CD25, CD127 and CD7 (Fig. 6). 
However, it should be noted that the frequency of Tc2 cells varied considerably, from 0.09 to 
16.8% of CD8+ T cells, in different individuals. Although there was a decrease in type 2 cytokine-
producing CD8+ cells, there was no decrease in Tc2 cells after deworming, which might indicate 
that factors other than helminths can induce these cells, or historical rather than current exposure 
to helminths is more decisive in driving the expansion of these cells. 
 
IL10-producing B and CD4+ T cells revealed by mass cytometry 
Similarly, we sought cells that produced the suppressor cytokine IL-10 to further understand the 
regulatory network. The IL-10-producing CD45+ cells were analysed in Cytosplore (Fig. 7A-B) 
and clustering on surface markers revealed a major cluster of CD4+ T cells, and minor clusters of 
CD8+ T cells, CD4-CD8- T cells and B cells (Fig. 7C-D, Fig. S4). Unlike what was seen with 
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CTLA-4 expression, no differences in frequencies of total IL-10-producing cells (relative to 
CD45+ cells) were observed among Europeans and rural Indonesians (EU 0.5% (median), ID Pre 
0.5% of total CD45+ cells, P = 0.86), and these did not change after anthelmintic treatment (ID Pre 
0.4 % of total CD45+ cells, P = 0.40).  
 Interestingly, a distinct population of IL-10+ B cells (0.5% of total B cells) was identified 
and further analysis showed that it consisted of three clusters, namely CD11c+CD38-, CD11c-
CD38+ and CD11c-CD38- cells (Fig. 7E). Whereas the composition of IL-10+ B cells did not 
change after deworming, IL-10+ B cells from rural Indonesians clearly contained more 
CD11c+CD38- cells compared to Europeans, who had relatively more CD11c-CD38+ IL-10+ B 
cells (Fig. 7F). These results indicate a different phenotype of IL-10+ B cells in the two 
populations, which is in line with significantly more CD11c+ B cells, representing chronically 
stimulated cells, in rural Indonesians compared to Europeans (EU 5.0% (median), ID Pre 13% of 
total B cells, P < 0.01).  
 When IL-10-producing CD4+ T cells were clustered on cytokines, four clusters were 
identified which all expressed type 2 cytokines but varied in terms of co-expression of other 
cytokines (IFNγ, TNFα, and/or IL-2) (Fig. 7G-H). When considering all CD4+ T cells producing 
IL-10 and type 2 cytokines, irrespective of other cytokines, their frequency was higher in rural 
Indonesians compared to Europeans. However, only the IL-10 and type 2 cytokine-producing 
cluster that was negative for IFNγ, TNFα, and IL-2 (cluster 1) decreased after deworming (Fig. 
7I).  
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The immune profile of urban Indonesians resembles that of Europeans rather than rural 
Indonesians 
We next sought to assess whether ethnic differences were driving the observed differences between 
Europeans and rural Indonesians. Therefore, we analysed a second cohort of eight Europeans eight 
Indonesians from urban centers, such as central Jakarta, where helminth infections are not found 
(urban Indonesians) (41), and eight Indonesians from the rural setting with current helminth 
infection (rural Indonesians) (table S1 and table S2). The same CyTOF panels and analysis strategy 
were used for the 14.3 million unstimulated and 12.2 million stimulated cells measured in this 
independent cohort (Fig. 8 and Fig. S5 and S6).   
Increased frequencies of Th2 cells were present in Rural Indonesians compared to both 
European and urban Indonesians (Fig. 8A). Within Th2 cells, rural Indonesians had increased 
levels of CD161+ cells compared to Europeans and urban Indonesians (Fig. 8C,D). Although in 
this independent cohort total ILC2 frequencies were not increased in rural Indonesians based on 
surface markers (Fig. S5D), ILC2 subsets differed between populations (Fig. 8D). Similar to the 
initial cohort, rural Indonesians, and also urban Indonesians, had increased CCR6-KLRG1+ ILC2s 
compared to Europeans. Functionally, ILC2 and Th2 cells were also increased in rural Indonesians 
as increased type 2 cytokines were produced compared to Europeans, whereas urban Indonesians 
resembled Europeans (Fig. 8E,F).  
As observed in the original cohort, rural Indonesians had increased proportions of CD161+ 
and CTLA-4+ Tregs compared to Europeans and urban Indonesians (Fig. 8G,H). Total Tregs were 
also increased in rural Indonesians in this cohort compared to Europeans (Fig. S5E). IL-10+ B cells 
of rural Indonesians in the independent cohort were characterized by increased expression of 
CD11c compared to Europeans and urban Indonesians as in the original cohort (Fig. 8H,I). 
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Taken together, we found urban Indonesians resembled Europeans more closely than rural 
Indonesians, demonstrating that ethnic differences were not driving the altered immune profiles . 
Moreover, we were able to validate the main findings of altered type 2 and regulatory immune cell 
populations in an independent cohort.  
 A summary of the heterogeneity of the type 2 and regulatory cell phenotypes, and the type 
2-cytokine and IL-10 producing cells that align with Europeans, rural helminth-infected 
Indonesians (before and after anthelmintic treatment) and urban Indonesians is given in fig. S6.  
Discussion  
 
 Our study used mass cytometry  to analyze type 2 and regulatory immune cells of healthy 
Europeans, as well as of helminth-infected Indonesians before and one year after deworming, to 
start to understanding the heterogeneity in the immune response of populations living in different 
geographical areas. We have identified and shown the expansion of not only Th2 but also the rare 
ILC2 cells, both sources of type 2 cytokines, in helminth-infected Indonesians compared to 
Europeans. When considering the cells by their phenotype, Th2 cell frequencies significantly 
decreased after deworming, but the frequencies of ILC2s remained unchanged. However, the 
frequency of not only Th2 but also ILC2s producing type 2 cytokines declined after anthelmintic 
treatment, indicating decreased functional activity. There is very little known about the role of 
ILC2s in human helminth infections (43, 44). Although the identification of CRTH2 as a marker 
of human ILC2s has been a great advantage (45), only one study analyzed ILC2s using CRTH2 in 
the context of human helminth infection (44). This study found lower frequencies of ILC2s in 
Schistosoma haematobium-infected African children but in line with the trend in our study, the 
proportion of ILC2s increased 6 weeks after anthelmintic treatment (44). 
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We identified 8 ILC2 clusters based on the heterogeneous expression of KLRG1, CD45RA 
and CCR6, paving the way for future studies to investigate their specific function. Interestingly, 
we identified CD45RA+c-Kit+ ILC3s that did not express CCR6, a marker previously described to 
be expressed by ILC3s (33, 46), and hypothesize that this subpopulation might consist of the 
recently described ILC precursors, as these cells lack CCR6 expression and are CD45RA+ (47).  
There is increasing evidence for the heterogeneity of Th2 cells, for example, pathogenic 
effector Th2 (peTh2) cells have recently been found in patients with allergic eosinophilic 
inflammatory diseases, that have enhanced effector function as assessed by cytokine production 
(48, 49). It is thought that chronic antigen exposure drives peTh2 cells, characterized as 
CD161+hPGDS+CD27-, to differentiate from conventional Th2 cells, however, it is not known 
whether peTh2 cells are induced by human helminth infections (49). Here, we describe the increase 
of a peTh2-like CD27-CD161+ subset of Th2 cells in helminth-infected individuals which 
significantly decreased after deworming. Given the general lack of severe allergic diseases in rural 
areas where helminths are endemic (50), it would be interesting to assess whether in subjects 
chronically infected with helminths these cells, have a more regulated function and thus less 
pathogenic activity. 
Tregs have been described as a heterogeneous population with differing expression of 
HLA-DR (51), ICOS (52) and CD38 (53) within the FOXP3+ Treg population. Functionally, Tregs 
expressing HLA-DR or CD38 have been shown to be highly suppressive (51, 53) and whereas the 
expression of ICOS has been suggested to define a Treg subset that has the capacity to produce 
large amounts of IL-10, ICOS- Tregs seem to produce mainly TGF-β (52). Moreover, a recent 
study has reported an interesting subset of Tregs expressing CD161 (38). By using mass cytometry, 
we could not only confirm the presence of these distinct Treg phenotypes in our study population, 
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but also visualize the marker distribution which revealed that all HLA-DR+, ICOS+, CD38+ and 
CD161+ cells were found within the CTLA-4+ Treg subset.  
 Although total Treg frequencies were not expanded in helminth-infected individuals and 
no treatment-related change was observed, when considering them at the subset level, the 
proportion of CTLA-4+ Tregs was significantly higher in helminth-infected individuals and 
declined after treatment, consistent with previous work in children from the same study area (18, 
21). Analysis at the cluster level revealed that the CTLA-4+ clusters in particular, often co-
expressing ICOS and/or HLA-DR and/or CD38, were expanded in rural Indonesians compared to 
Europeans, indicating that helminths induce a particular Treg phenotype which could be 
represented by cells with increased regulatory capacity (21). We also found a significantly higher 
proportion of CD161+ Tregs in rural Indonesians compared to Europeans and given that this 
population was shown to accelerate epithelial barrier healing in the gut (38), they might play a role 
in healing of the wounds caused by soil-transmitted helminths, either during their migration 
throughout the body or upon their residence in the intestine.  
Besides Th2 cells and ILC2s being a source of type 2 cytokines, we identified Tc2 cells 
(type 2 cytokine-secreting CD8+ T cells (39)) and a cluster of γδ T cells, which produced type 2 
cytokines. Although Tc2 cells have recently been found to be enriched in patients with eosinophilic 
asthma (40), this current study characterizes these cells in the context of human helminth 
infections. Like Tc2 cells, not much is known about type 2 cytokine-producing γδ T cells, although 
their existence has been described before (54-58). Inagaki et al. showed a protective role of γδ T 
cells against infection with N. brasiliensis in mice, which was associated with the production of 
type 2 cytokines, in particular IL-13 (55). However, to our knowledge, the presence of type 2 
cytokine-producing γδ T cells in human helminth infection has not been previously reported. With 
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the increasing recognition of the role γδ T cells play in shaping adaptive responses in infectious 
diseases (59, 60), it would be interesting to delineate their possible participation in the 
development of Th2 responses.  
IL-10 producing B cells, known as regulatory B cells (Bregs), represent a relatively rare 
cell type that can suppress inflammatory responses (61). The frequency of IL-10 producing B cells 
was similar in Europeans and Indonesians and deworming did not affect their frequency. However, 
the phenotype of these cells was strikingly different with relatively more CD11c+CD38-, and less 
CD11c-CD38+ IL-10+ B cells present in Indonesians. There is increasing evidence that CD11c+ B 
cells are a distinct population of memory B cells, and they have been shown to expand in settings 
of chronic infections such as HIV, malaria and TB as well as in several autoimmune diseases (62, 
63). Our finding of a significantly expanded population of CD11c+Tbet+ B cells in Indonesians 
with chronic helminth infection, of which a small fraction appeared capable of producing IL-10,  
indicates that through the use of mass cytometry, it becomes possible to identify novel cell types 
that would need to be investigated for their properties including suppressor functions.  
Here, we demonstrate the advantage of using mass cytometry combined with HSNE, which 
allowed the identification of rare cell populations, such as ILC2s, Tc2 cells and Bregs, and 
provided an opportunity to analyze the heterogeneity within Th2 cells and Tregs. A comparison of 
urban and rural Indonesians and Europeans demonstrates that the alterations in type 2 and 
regulatory immune cells were not due to ethnic differences as immune profiles of Indonesians 
resembled that of Europeans more than rural Indonesians. A strength of this study is that we 
validated these findings in an independent cohort, demonstrating the robustness of these findings. 
Limitations of our study include analyzing peripheral immune cells from a relatively small number 
of individuals. Additionally, there is a lack of placebo-treated individuals and the possibility that 
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other infections are affected by deworming. However, this study is a stepping stone to verify the 
findings in larger studies that allow detailed delineation of their function not only in helminth 
infections but also in other disease settings. 
 
 
 
 
 
 
 
Materials and Methods 
 
Study design  
The objective of this study was to profile type 2 and regulatory immune responses in Europeans 
and in helminth-infected Indonesians, before and 1 year after deworming, by applying mass 
cytometry on peripheral blood samples. The Indonesian samples were part of the SugarSPIN trial, 
a household-based cluster-randomized double-blind trial that was conducted in three rural villages 
in Nangapanda, Ende district of Flores island (East Nusa Tenggara), Indonesia (64). The trial was 
approved by the ethics committee of Faculty of Medicine, Universitas Indonesia (FKUI) (ref: 
549/H2·F1/ETIK/2013), and filed by the ethics committee of Leiden University Medical Center 
(LUMC). The trial is registered as a clinical trial (Ref: ISRCTN75636394). Written informed 
consent was obtained from participants prior to the study.  
 We were interested in subjects who were helminth-infected and successfully treated with 
albendazole (n=56). The treatment consisted of a single tablet of albendazole (400 mg; PT 
Indopharma Pharmaceutical, Bandung, Indonesia) for three consecutive days, and this regimen 
was given every three months for a total of four rounds (maximum of 12 tablets in total), between 
18 
 
May 2014 and February 2015. Before the start of drug administration and 6 weeks after the last 
round of drug administration, blood and stool samples were collected as previously described (64). 
To ensure that the subjects that were studied were unlikely to have become re-infected 
(subpatently), we selected subjects in whom eosinophils and IgE were decreased after treatment 
(n=10). Finally, age- and sex-matched samples of healthy volunteers, from the Netherlands 
(Caucasians) or from urban centers in Indonesia, such as central Jakarta, with no helminth 
infections  were included in the study (Table S1 and Table S2). Primary data are reported in data 
file S1. 
 
Parasitology 
Aliquots of fresh stool samples were frozen at -20°C in the field study centre and subsequently at 
-80°C at the Department of Parasitology of FKUI and LUMC for DNA extraction. Stool DNA 
isolation and real-time PCR were performed pairwise (baseline and follow-up). DNA isolation 
from stool was performed as described elsewhere (65). Multiplex real-time polymerase chain 
reaction (PCR) was performed to simultaneously detect the presence of hookworm (Ancylostoma 
duodenale, Necator americanus), Ascaris lumbricoides, Trichuris trichiura, and Strongyloides 
stercoralis, using a method described previously (65). Stool samples were considered positive by 
PCR when cycle threshold (Ct) values were <50.  
 
Eosinophil count and total IgE 
A Giemsa-stained peripheral thin blood smear was read to assess the differential white blood cell 
count, resulting in a relative percentage of basophils, eosinophils, neutrophils, lymphocytes and 
monocytes. Total IgE was measured in serum as described previously (66). 
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PBMC cryopreservation 
After diluting heparinised venous blood 2x with HBSS, PBMCs were isolated using Ficoll density 
gradient centrifugation within 12 hours after blood collection. The HBSS contained 100 U/mL 
penicillin G sodium and 100 µg/mL streptomycin. After washing twice with HBSS, the PBMCs 
were cryopreserved in RPMI 1640 containing 20% of heat-inactivated fetal calf serum (FCS; 
Bodinco) and 10% dimethyl sulfoxyde (DMSO). The RPMI medium contained 1 mM pyruvate, 2 
mM L-glutamine, penicillin G and streptomycin. Cryovials containing the cell suspension were 
transferred to a Nalgene Mr Frosty Freezing Container (Thermo Scientific) which was placed at a 
-80°C freezer for a minimum of 4 hours. Subsequently, vials were stored in liquid nitrogen until 
analysis. The cryopreserved PBMCs collected in the field were shipped in a liquid nitrogen dry 
vapor shipper from Jakarta, Indonesia, to Leiden, the Netherlands, for analysis.  
 
Mass cytometry antibody staining  
Two antibody panels were designed to 1) phenotype immune cells ex vivo and 2) assess cytokine 
production after 6 hours of stimulation with phorbol 12-myristate 13-acetate (PMA) and 
ionomycin. Details on antibodies used are listed in tables S3 and S4. Antibody-metal conjugates 
were either purchased or conjugated using a total of 100 μg of purified antibody combined with 
the MaxPar X8 Antibody Labelling Kit (Fluidigm) according to manufacturer’s protocol V7. The 
conjugated antibody was stored in 200 µL Antibody Stabilizer PBS (Candor Bioscience, GmbH) 
at 4°C. All antibodies were titrated on study samples.  
On the day of the staining, cryopreserved PBMCs were thawed with 50% FCS/RPMI 
medium at 37°C and washed twice with 10% FCS/RPMI medium. Next, 3x106 cells per sample, 
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used for phenotyping (Panel 1), were stored on ice temporarily while another 3x106 cells per 
sample were transferred to 5 ml round-bottom Falcon tubes (BD Biosciences) for 6 hours of 
incubation in 10% FCS/RPMI with 100 ng/mL PMA (Sigma) and 1 µg/mL ionomycin (Sigma). 
After 2 hours of incubation at 37°C, 10 µg/mL brefeldin A (Sigma) was added after which the 
cells were incubated for 4 more hours. Subsequently, the cells were washed with PBS and 
resuspended in MaxPar staining buffer (Fluidigm) before continuing with the antibody staining 
(Panel 2). 
For phenotyping (Panel 1), the staining was based on MaxPar Nuclear Antigen Staining 
Protocol V2 (Fluidigm). First, cells were washed with MaxPar staining buffer and centrifuged for 
5 minutes at 300g in 5 mL eppendorf tubes. Then, the cells were incubated with 1 mL 500x diluted 
500 µM Cell-ID Intercalator-103Rh (Fluidigm) in staining buffer at room temperature for 15 
minutes to identify dead cells. After washing with staining buffer, cells were incubated with 5 µL 
Human TruStain FcX Fc-receptor blocking solution (BioLegend) and 40 µL staining buffer at 
room temperature for 10 minutes. Then, 50 µL of freshly prepared surface antibody cocktail was 
added and incubated at room temperature for another 45 minutes. Subsequently, cells were washed 
2x with staining buffer and fixed and permeabilized using the eBioscience FOXP3/Transcription 
factor staining buffer set (eBioscience). After cells were incubated with 1 mL of the freshly 
prepared Fix/Perm working solution (prepared according to the manufacturer’s instructions) for 
45 minutes, cells were washed 2x with 1x Permeabilization buffer at 800g for 5 minutes. Next, 50 
µL of the intranuclear antibody cocktail was added to 50 µL of cells resuspended in 1x 
Permeabilization buffer and incubated for 30 minutes at room temperature. Following the 
incubation, cells were washed once with 1x Permeabilization buffer and twice with staining buffer, 
before being stained with 1 mL 1000x diluted 125 µM Cell-ID Intercalator-Ir (Fluidigm) in 
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MaxPar Fix and Perm buffer (Fluidigm) at 4°C overnight to stain all cells. After 3 washes with 
staining buffer and centrifugation at 800 g, cells were stored as a pellet at 4°C and measured within 
2 days. 
To assess the cytokine production of PBMCs (Panel 2), the staining was based on MaxPar 
Cytoplasmic/Secreted Antigen Staining Protocol V3. While the surface staining was performed 
exactly as described above, cells were afterwards fixed by incubating them with 1 mL of freshly 
prepared 1x MaxPar Fix I buffer (Fluidigm) for 20 minutes at room temperature. Next, cells were 
washed 3x with MaxPar Perm-S buffer (Fluidigm) and 50 µL of cytokine antibody cocktail was 
added to 50 µL of cell suspension and incubated for 40 minutes at room temperature. Then, cells 
were washed 3x with staining buffer and stained with Cell-ID Intercalator-Ir as described above.  
 
Mass cytometry data acquisition 
Measurement of samples was randomised per subject to avoid bias, but samples belonging to the 
same subject were stained and measured together. Samples were measured with a Helios mass 
cytometer (Fluidigm), which was automatically tuned according to Fluidigm’s recommendations. 
Before measuring, cells were counted, washed with Milli-Q water, passed over a cell strainer, and 
brought to a concentration of 1.0x106 cells/mL with 10% EQ Four Element Calibration Beads 
(Fluidigm) in Milli-Q water. Mass cytometry data were acquired and analysed on-the-fly, using 
dual-count mode and noise-reduction on. Next to channels to detect antibodies, channels for 
intercalators (103Rh, 191Ir, 193Ir), calibration beads (140Ce, 151Eu, 153Eu, 165Ho, and 175Lu) 
and background/contamination (133Cs, 138Ba, 206Pb) were acquired. After data acquisition, the 
mass bead signal was used to normalize the short-term signal fluctuations with the reference EQ 
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passport P13H2302 during the course of each experiment. When applicable, normalized FCS files 
were concatenated using Helios software, without removing beads.  
 
Mass cytometry data analysis 
FlowJo V10 for Mac (FlowJo LLC) was used to gate out beads and we discriminated live, single 
CD45+ immune cells with DNA stain and event length. The selected cells were exported as FCS 
files and analysed using HSNE (25), as implemented in Cytosplore (26, 67). HSNE constructs a 
hierarchy of non-linear similarities that can be interactively explored with a stepwise increase in 
detail up to the single-cell level (26). Briefly, the data exploration starts with the visualization of 
the embedding at the highest level, the overview level, where the layout of the landmarks 
(representative cells) indicates similarity in the high-dimensional space. The landmark size reflects 
its area of influence (AoI), containing cells that are well-represented by the landmark, and the 
similarity of two landmarks is defined as the overlap of their respective AoIs. Colouring of the 
landmarks is used to represent marker expressions. At the overview level, a group of landmarks 
(also referred to as cluster) can be selected, by manual gating based on visual cues such as marker 
expression, or by performing unsupervised Gaussian mean shift (GMS) clustering (67, 68) of the 
landmarks based on the density representation of the embedding. Next, we can zoom into this 
selection by means of a more detailed embedding and visualize all selected landmarks in a next 
level. While this process can be repeated until the data level is reached where each dot represents 
a single cell, this is not imperative and we often clustered at an intermediate level without reaching 
the data level. The number of hierarchical levels depended on the input-data size.  
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Before HSNE was applied, data were transformed using a hyperbolic arcsin with a cofactor 
of 5. Furthermore, within Cytosplore, an extra channel called ‘SampleTag’ was added to the FCS 
files to be able to identify from which sample an event originated after HSNE.  
Clusters produced in Cytosplore were analysed using R software (R x64 version 3.5.1; R 
Foundation for Statistical Computing) and RStudio (Rstudio, Inc). The package ‘cytofast’ was 
used to produce heatmaps, scatterplots showing subset abundance and histograms showing the 
median signal intensity distribution of markers (69). 
 
Statistical Analysis 
Statistical analyses were performed using R software. To compare subpopulation and cluster 
abundance between Europeans and Indonesians pre-treatment unpaired t tests were used. Paired t 
tests were applied to compare pre- and post-treatment samples of Indonesians. Total IgE and 
eosinophil counts were log-transformed for analysis and paired t tests were used in GraphPad 
Prism (GraphPad Software). Spearman’s correlation was used to assess the relationship between 
the frequency of Tc2 cells and type 2 cytokine-producing CD8+ T cells. P values < 0.05 were 
considered statistically significant. For comparison of three groups in the second cohort, ANOVA 
followed by Tukey’s post-test were used with one-sided testing based on the differences identified 
in the first cohort. 
 
Supplementary Materials 
Fig. S1. Lineage frequencies. 
Fig. S2. Eosinophil counts and total IgE in rural Indonesians.  
Fig. S3. Type 2-cytokine producing cells. 
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Fig. S4. IL-10 producing cells.   
Fig. S5. Immune composition of Europeans, urban and rural Indonesians. 
Fig. S6. Heatmap summary. 
Table S1. Characteristics of the study cohorts. 
Table S2. Helminth infection details of rural Indonesians. 
Table S3. Antibody panel 1 (Phenotyping).  
Table S4. Antibody panel 2 (Cytokine production). 
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Figure legends 
Figure 1. Distinct immune signatures between Europeans and Rural Indonesians. (A) First 
HSNE level embedding of 20.3 million peripheral immune cells from Europeans (n=10) and rural 
Indonesians infected with helminths (n=10), before and after 1 year of deworming. In all figures, 
color represents arsin5-transformed marker expression as indicated. Size of the landmarks 
represents area of influence (AoI). (B) The major immune lineages, annotated on the basis of 
lineage marker expression. (C) Comparison of lineage proportions relative to total cells between 
Europeans (EU) and rural Indonesians (ID). Differences between EU and ID were tested with 
Student’s t test. *P <0.05. (D) Second HSNE level embedding of the CD4+ landmarks selected 
from the overview level of total PBMCs, as indicated by the red circle. Both landmarks (left panel) 
and the density features of the CD4+ T cells (right panel) are shown. Density is indicated by color. 
(E) Density plots per lineage, stratified by sample origin. 
 
Figure 2. A CD161+ subpopulation of Th2 cells is expanded in rural Indonesians and 
decreases after anthelmintic treatment. (A) Fourth HSNE level embedding of the CRTH2+ 
landmarks (Th2 cells) selected from the second HSNE level embedding of 6.3 million CD4+ T 
cells, as indicated by the black circle. All cells in third level were selected for the fourth level. (B) 
Frequency of Th2 cells relative to CD4+ T cells. Differences between EU (n=10) and rural ID pre-
treatment (ID Pre, n=10) were tested with Student’s t test, whereas differences between ID Pre and 
ID Post (n=10) were assessed using paired t tests. **P <0.01. (C) Cluster partitions of Th2 cells 
using density-based GMS clustering. The black circle indicates three subpopulations. (D) Marker 
expression of CD27 and CD161 on Th2 cells. (E) Density features of Th2 cells. (F) Frequency of 
three Th2 subpopulations (CD161+CD27-, CD161-CD27-, CD161-CD27+) relative to total Th2 
cells. *P <0.05. (G) A heatmap summary of median expression values (same colour coding as for 
the embeddings) of cell markers expressed by CRTH2+ clusters identified in Fig. 2C and 
hierarchical clustering thereof. To compare cluster abundance between EU and ID Pre Student’s t 
test was used, whereas paired t test was used to compare ID Pre and ID Post. Coloured symbols 
below the clusters indicate statistical significance. 
 
Figure 3. Overall frequency of ILC2s is expanded in rural Indonesians but does not decrease 
after anthelmintic treatment. (A) The right panel shows the third HSNE level embedding of the 
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CD25+CD161+CD127+ landmarks selected from the second HSNE embedding of 2.8 million ILCs 
(CD3-CD7+) shown in the left panel, and indicated by the black circle. (B) Frequency of ILC2s 
relative to total CD45+ cells. Differences between EU (n=10) and ID Pre (n=10) were tested with 
Student’s t test, whereas differences between ID Pre and ID Post (n=10) were assessed using paired 
t tests. **P <0.01. (C) Data level embedding of ILC2s. The upper left panel shows the cluster 
partitions using GMS clustering, whereas the other panels show the expression of KRLG1, CCR6 
and CD45RA. (D) A heatmap summary of median expression values (same colour coding as for 
the embeddings) of cell markers expressed by ILC2 cell clusters identified in Fig. 3C. and 
hierarchical clustering thereof. To compare cluster abundance between EU and ID Pre Student’s t 
test was used, whereas paired t test was used to compare ID Pre and ID Post. Coloured symbols 
below the clusters indicate statistical significance. 
 
Figure 4. Helminth infections increase the expression of inhibitory molecules on Tregs. (A) 
Fourth HSNE level embedding of the FOXP3+ landmarks (Tregs) selected from the second HSNE 
embedding of 6.3 million CD4+ T cells, as indicated by the black circle. All cells from the third 
level were selected. (B) Frequency of Tregs relative to CD4+ T cells. Differences between EU 
(n=10) and ID Pre (n=10) were tested with Student’s t test, whereas differences between ID Pre 
and ID Post (n=10) were assessed using paired t tests. (C). Frequency of CD45RO+ effector Tregs 
relative to total Tregs. *P <0.05. (D) Density features of Tregs. (E) Marker expression of CTLA-
4, ICOS, CD38, HLA-DR and CD161 by Tregs. (F) Frequency of CTLA-4+ Tregs relative to total 
Tregs. *P <0.05; **P <0.01. (G) Treg cluster partitions using GMS clustering. (H) A heatmap 
summary of median expression values (same colour coding as for the embeddings) of cell markers 
expressed by FOXP3+ Treg clusters identified in Fig. 4G. and hierarchical clustering thereof. To 
compare cluster abundance between EU and ID Pre Student’s t test was used, whereas paired t test 
was used to compare ID Pre and ID Post. Coloured symbols below the clusters indicate statistical 
significance. (I) Frequency of CD161+ Tregs relative to total Tregs. *P <0.05. 
 
Figure 5. Type 2 cytokine-producing cells (ILC2s, CD4+, CD8+ and γδ T cells) and their 
alteration after deworming in rural Indonesians. (A) IL-4/5/13+ cells were manually gated 
using Flowjo. Data from one representative individual is shown. (B) First HSNE level embedding 
of total IL-4/5/13+ cells, clustered on surface markers. (C) Density features of IL-4/5/13+ cells. (D) 
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The major immune cell subpopulations producing type 2 cytokines, annotated on the basis of 
lineage marker expression (See Fig. S3). (E) Histogram showing the median signal intensity (MSI) 
distribution of IL-4/5/13 and IFNγ for the subpopulations identified in Fig. 5D. (F) Marker 
expression of CD25 and IFNγ by IL-4/5/13+ cells. (G) Frequency of total IL-4/5/13-producing 
cells relative to total CD45+ cells. Differences between EU (n=10) and ID Pre (n=10) were tested 
with Student’s t test, whereas differences between ID Pre and ID Post (n=10) were assessed using 
paired t tests. **P <0.01. (H) Frequency of IL-4/5/13-producing clusters identified in Fig. 5D. 
relative to total CD4+ T, ILC2, γδ T or CD8+ T cells. *P <0.05; **P <0.01. 
 
Figure 6. Tc2 cells are the source of type 2 cytokines produced by CD8+ T cells. (A) CCR7-
CD161-CD56- landmarks were selected from the second level HSNE embedding of CD8+ T cells, 
as indicated by the black circle. (B) From the next level embedding, GATA3+ landmarks were 
selected and their marker expression is shown at the fourth level embedding.(C) Correlation of 
type 2 cytotoxic T (Tc2) cells identified in B-C and IL-4/5/13-producing CD8+ T cells identified 
in Fig. 5D. Colors indicate paired samples (pre and post treatment) from Indonesian individuals 
(n=10), black dots represent European individuals (n=10). Spearman’s rank correlation was used 
for statistical analysis. 
 
Figure 7. IL-10-producing B and CD4+ T cells revealed by mass cytometry. (A) IL-10+ cells 
were manually gated using Flowjo. Data from one representative individual is shown. (B) First 
HSNE level embedding of total IL-10+ cells, clustered on surface markers. (C) Density features of 
IL-10+. (D) The major immune cell subsets producing IL-10, annotated on the basis of lineage 
marker expression (See Fig. S4). (E) Data level embedding of IL-10+ B cells and the cluster 
partitions using GMS clustering (lower right panel). (F) Relative composition of IL-10+ B cells, 
comparing EU (n=10) and ID Pre (n=10). Below, density features of IL-10+ B cells are shown. (G) 
First level HSNE embedding of IL-10+CD4+ landmarks selected in Fig. 7D and clustered on 
cytokines. Four IL-4/5/13+ clusters were identified as indicated in the right panel showing the 
cluster partitions. (H) Histograms showing the median signal intensity (MSI) distribution of 
cytokines for the four clusters identified in Fig. 7G. (I) Frequency of cluster 1, co-expressing IL-
4/5/13 and IL-10 (identified in Fig. 7G), relative to total IL-10-producing CD4+ T cells. 
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Differences between EU and ID Pre were tested with Student’s t test, whereas differences between 
ID Pre and ID Post (n=10) were assessed using paired t tests. *P <0.05; **P <0.01. 
 
Figure 8. The immune profile of urban Indonesians is more similar to Europeans than rural 
Indonesians (A) Frequency of Th2 cells relative to CD4+ T cells. Differences between EU (n=8), 
Indonesians from urban settings without helminth infections (urban ID, n=8) and rural Indonesians 
infected with helminths (rural ID, n=8) were tested with ANOVA followed by Tukey’s post-test. 
**P <0.01, ***P <0.001. (B) Third HSNE level embedding of the Th2 cells and theirdensity 
features . (C) Frequency of CD161+CD27- cells within Th2 cells. *P <0.05, **P <0.01. (D) Data 
level embedding of ILC2s. The upper right panel shows the cluster partitions using GMS 
clustering, whereas the other panels show the expression of KRLG1, CCR6 and CD45RA. Right 
panel shows the frequency of CCR6-KLRG1+ cells within ILC2s. *P <0.05, **P <0.01. (E) 
Frequency of IL4/5/13 producing cells within CD4+ T cells. **P <.01, ***P <0.001. (F) Frequency 
of IL4/5/13 producing cells within ILC2s. *P <0.05. (G) Frequency of CD161+ (left panel) and 
CTLA-4+ (right panel) cells within Tregs. *P <0.05, **P <0.01, ***P <0.001. (H) Data level 
embedding of IL-10+ B cells and the cluster partitions using GMS clustering (lower right panel), 
whereas the other right panels show the expression of CD11c, CD38 and the density features in 
left panels. (I) Frequency of CD11c+ cells within IL10-producing B cells. **P <0.01. 
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Figure 8 
 
 Supplementary Figures 
Fig. S1. Lineage frequencies. Scatterplots comparing lineage frequencies of Europeans (EU, n=10) and rural 
Indonesians (ID, n=10). Median is shown. Differences -test. *P 
<0.05. 
  
Fig. S2. Eosinophil counts and total IgE in rural Indonesians. (A) Eosinophil counts expressed as percentage 
of white blood cells (WBC) and (B) Serum measurements of total IgE of Indonesians pre- and post-anthelmintic 
treatment (n=10). **P <0.01 -test. 
  
Fig. S3. Type 2 cytokine-producing cells. (A) First level embedding of IL-4/5/13+ cells from Europeans (n=10) 
and rural Indonesians infected with helminths (n=10), before and after 1 year of deworming,  clustered on 
surface markers. Lower right panel shows cluster partitions of IL-4/5/13+ cells using GMS clustering. The 
expression of CD4 was reduced as a consequence of the stimulation. Color represents arsin5-transformed marker 
expression as indicated. Size of the landmarks represents AoI. (B) Second level embedding of the CD3-CD7+ 
landmarks selected from the first level in fig. S3A, as indicated by the black circle, allowed the identification of 
ILC2s. (C) A heatmap summary of median expression values of cell markers expressed by IL-4/5/13+ cells 
identified in a. and hierarchical clustering thereof. 
  
 
 
 
 
Fig. S4. IL-10 producing cells. (A) First level embedding of IL-10+ cells from Europeans (n=10) and rural 
Indonesians infected with helminths (n=10), before and after 1 year of deworming, clustered on surface markers. 
The expression of CD4 was reduced as a consequence of the stimulation. Color represents arsin5-transformed 
marker expression as indicated. Size of the landmarks represents AoI. (B) Cluster partitions of IL-10+ cells using 
GMS clustering. (C) A heatmap summary of median expression values of cell markers expressed by IL-10+ cells 
identified in fig. S4B and hierarchical clustering thereof. 
 
Fig. S5. Immune composition of Europeans and urban and rural Indonesians. (A) First HSNE level 
embedding of 14.3 million unstimulated cells. Color represents arsin5-transformed marker expression as 
indicated. Size of the landmarks represents AoI. (B) Comparison of lineage proportions relative to total cells 
between Europeans (EU, n=8)), Urban (n=8) and Rural (n=8) Indonesians (ID). (C) Density plots per lineage, 
stratified by sample origin, and therefore illustrating the differences and similarities between EU and Rural and 
Urban ID. (D) The top panel shows the second HSNE embedding of 2.2 million ILCs (CD3-CD7+), with color 
indicating CD25 expression. Cells within the black circle were selected and shown in the bottom panel is the 
third HSNE level embedding of the CD25+CD161+CD127+ ILC. The right panel shows the frequency of ILC2s, 
indicated by black circle relative to total CD45+ cells. (E) The left panels show the second HSNE level 
embedding of CD4+ T cells, with color representing arsin5-transformed FOXP3 and CD25 marker expression as 
indicated. The right panel shows the frequency of Tregs relative to CD4+ T cells. Differences between groups 
-test. *P <0.05. 
   
Fig. S6. Heat map summary. A heatmap summary showing the median cluster abundance of clusters identified 
in Fig. 2 (Th2), Fig. 3 (ILC2s), Fig. 4 (Tregs), Fig. 8 (second cohort including urban Indonesians), fig. S3 (type 2 
cytokine-producing cells), fig. S4 (IL-10-producing cells) and fig. S5 (second cohort surface panel). Colored 
lines highlight a cluster(set) expressing a particular marker. Heatmaps are shown for both the first cohort (top) 
and the second cohort (bottom). (A) Cluster abundance relative to the number of CD45+ cells. (B) Cluster 
abundance relative to the total number of its corresponding cell type (e.g. CD4+ T cells, ILC2s, CD8+ 
cells). (C) Cluster abundance relative to the total number of its corresponding cell type (e.g. CD4+ T, CD19+ B 
cells). EU, Europeans; ID Pre, Rural Indonesians pre-treatment; ID Post, Rural Indonesians post-treatment. ID 
Urban, Indonesians from urban centers; ID Rural, helminth-infected Indonesians from a rural setting. 
 
Supplementary Tables 
Table S1. Characteristics of the study cohorts. 
 
 
 
 
 
 
 
 
 
 
 
Characteristic  first cohort Europeans (n=10) Indonesians (n=10) 
Age, years (median, min, max) 32 (26-55) 36 (18-56)
Sex, female, n 5  5 
Eosinophil count, %, (GM, min, max) na 13.7 (9-28) 
Total IgE, IU/mL, (GM, min, max) na 823 (124-7753) 
Helminth infection by PCR, No. 
Single 
Multiple 
  
na  
  
5 
5 
Characteristic  second cohort EU (n=8) Urban ID (n=8) Rural ID (n=8) 
Age, years (median, min, max) 28 (22-32) 31 (18-37) 38 (18-54) 
Sex, female, n 6 4 4 
Eosinophil count, %, (GM, min, max) na na 13.5 (9-28) 
Total IgE, IU/mL, (GM, min, max) na na 2498 (804-9999) 
Helminth infection by PCR, No. 
Single 
Multiple 
na 
 
na  
3 
5 
GM, geometric mean; na, not applicable 
GM, geometric mean; na, not applicable; EU, European; ID, Indonesian 
Table S2. Helminth infection details of rural Indonesians. 
 
 
Subject characteristics PCR (Ct value) 
ID Cohort Age BMI Sex Al Hw Tt Ss 
36 First 17 18.3 Male Neg 28.4 33.4 Neg 
449 First 55 21.1 Male Neg 38.5 Neg Neg 
577 First 37 30.4 Female Neg Neg 32.3 Neg 
596 First 55 19.6 Male 30.2 28.5 37.9 Neg 
769 First 35 20.4 Female 25.6 27.8 28.5 Neg 
897 First 46 26.8 Male Neg 30.2 Neg 29.5 
3702 First 18 17.6 Male 31.8 32.3 30.0 Neg 
6324 First 35 19.5 Female Neg Neg 35.6 Neg 
7200 First 28 20.2 Female Neg 31.1 Neg Neg 
7878 First 24 21.8 Female Neg 34.4 Neg Neg 
55 Second 18 16.3 Male Neg 28.3 Neg Neg 
633 Second 38 20.9 Male 34.4 32.5 Neg Neg 
2147 Second 38 25.5 Female Neg Neg 34.3 Neg 
2176 Second 54 20.8 Female 27.4 30.8 32.3 Neg 
3460 Second 41 22.0 Female Neg 41.3 Neg Neg 
3713 Second 53 26.1 Female Neg 28.4 27.2 Neg 
6106 Second 31 19.1 Male Neg 30.3 34.1 31.7 
7697 Second 31 18.7 Male 31.5 37.1 Neg Neg 
Table S3. Antibody panel 1 (phenotyping). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CCR, C-C chemokine receptor. CD, cluster of differentiation. CRTH2, prostaglandin D2 receptor 2. CXCR, CXC 
chemokine receptor. FOXP3, forkhead box P3. HLA-DR, human leukocyte antigen-D-related. IL-2R, interleukin-2 
receptor. IL- -7 receptor -like receptor subfamily G member 1. MAFA, 
mast cell function-associated antigen. PD-1, programmed cell death protein. TCR, T-cell receptor. Markers in gray 
were stained intranuclear, while all other markers were stained on the cell surface. 
Label Specificity Clone Vendor Catalogue number Dilution
89Y CD45 HI30 Fluidigm 3089003B 200x 
113CD CD45RA HI100 eBioscience 83-0458-42 50x 
141Pr CD196 (CCR6) G034E3 Fluidigm 3141003A 100x 
142Nd CD19 HIB19 Fluidigm 3142001B 200x 
143Nd CD117 (c-Kit) 104D2 Fluidigm 3143001B 100x
145Nd CD4 RPA-T4 Fluidigm 3145001B 100x 
146Nd CD8a RPA-T8 Fluidigm 3146001B 200x 
147Sm CD183 (CXCR3) G025H7 BioLegend 353733 100x 
148Nd CD14 M5E2 BioLegend 301843 100x 
149Sm CD25 (IL-2Ra) 2A3 Fluidigm 3149010B 100x 
150Nd CD185 (CXCR5) J252D4 BioLegend 356902 100x 
151Eu CD123 6H6 Fluidigm 3151001B 100x 
152Sm  11F2 Fluidigm 3152008B 50x 
153Eu CD7 CD7-6B7 Fluidigm 3153014B 100x 
154Sm CD163 GHI/61 Fluidigm 3154007B 100x 
155Gd CD278 (ICOS) C398.4A BioLegend 313502 50x 
156Gd CD294 (CRTH2) BM16 BioLegend 350102 50x 
158Gd CD122 (IL-2Rb) TU27 BioLegend 339015 100x 
159Tb CD197 (CCR7) G043H7 Fluidigm 3159003A 100x 
160Gd FOXP3 PCH101 eBioscience 14-4776-82 50x 
161Dy KLRG1 (MAFA) REA261 Miltenyi Special order 100x 
162Dy CD11c Bu15 Fluidigm 3162005B 200x 
163Dy CD152 (CTLA-4) BNI3  BioLegend 369602 100x 
164Dy CD161 HP-3G10 Fluidigm 3164009B 100x 
165Ho CD127 (IL-  AO19D5 Fluidigm 3165008B 200x 
166Er Tbet 4B10 BioLegend 644825 50x 
167Er CD27 O323 Fluidigm 3167002B 200x 
168Er HLA-DR L243 BioLegend 307651 200x 
169Tm GATA3 REA174 Miltenyi 130-108-061 50x 
170Er CD3 UCHT1 Fluidigm 3170001B 100x 
171Yb CD28 CD28.2 BioLegend 302937 200x 
172Yb CD38 HIT2 Fluidigm 3172007B 200x 
173Yb CD45RO UCHL1 BioLegend 304239 100x 
174Yb CD335 (NKp46) 92E BioLegend 331902 100x 
175Lu CD279 (PD-1) EH 12.2H7 Fluidigm 3175008B 100x 
176Yb CD56 NCAM16.2 Fluidigm 3176008B 100x 
209BI CD16 3G8 Fluidigm 3209002B 400x 
Table S4. Antibody panel 2 (cytokine production). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CCR, C-C chemokine receptor. CD, cluster of differentiation. CRTH2, prostaglandin D2 receptor 2. CXCR, CXC 
chemokine receptor. HLA-DR, human leukocyte antigen-D-related. IL-2R, interleukin-2 receptor. IL-
interleukin- ctin-like receptor subfamily G member 1. MAFA, mast cell function-
associated antigen. PD-1, programmed cell death protein. TCR, T-cell receptor. Markers in gray were stained 
intracellular, while all other markers were stained on the cell surface. 
 
Label Specificity Clone Vendor Catalogue number Dilution 
89Y CD45 HI30 Fluidigm 3089003B 200x 
113CD CD45RA HI100 Ebioscience 83-0458-42 50x 
141Pr CD196 (CCR6) G034E3 Fluidigm 3141003A 100x 
142Nd CD19 HIB19 Fluidigm 3142001B 200x 
143Nd CD117 (c-Kit) 104D2 Fluidigm 3143001B 100x 
144Nd IL-2 MQ117H12 BioLegend 500339 400x
145Nd CD4 RPA-T4 Fluidigm 3145001B 100x 
146Nd CD8a RPA-T8 Fluidigm 3146001B 200x 
147Sm CD183 (CXCR3) G025H7 BioLegend 353733 100x 
148Nd CD14 M5E2 BioLegend 301843 100x 
149Sm CD25 (IL-2Ra) 2A3 Fluidigm 3149010B 100x 
150Nd CD185 (CXCR5) J252D4 BioLegend 356902 100x 
151Eu CD123 6H6 Fluidigm 3151001B 100x 
152Sm  11F2 Fluidigm 3152008B 50x 
153Eu CD7 CD7-6B7 Fluidigm 3153014B 100x 
154Sm CD163 GHI/61 Fluidigm 3154007B 100x 
155Gd  B27 BioLegend 506521 400x 
156Gd CD294 (CRTH2) BM16 BioLegend 350102 50x 
158Gd CD122 (IL-2Rb) TU27 BioLegend 339015 100x 
159Tb CD197 (CCR7) G043H7 Fluidigm 3159003A 100x 
160Gd  MAb11 BioLegend 502941 400x 
161Dy KLRG1 (MAFA) REA261 Miltenyi Special order 100x 
162Dy CD11c Bu15 Fluidigm 3162005B 200x 
163Dy IL-17 BL168 BioLegend 512331 400x 
164Dy CD161 HP-3G10 Fluidigm 3164009B 100x 
165Ho CD127 (IL-7Ra) AO19D5 Fluidigm 3165008B 200x 
166Er IL-10 JES39D7 Fluidigm 3166008B 400x 
167Er CD27 O323 Fluidigm 3167002B 200x 
168Er HLA-DR L243 BioLegend 307651 200x 
169Tm IL-4 MP4-25D2 Fluidigm 3169016B 400x 
169Tm IL-5 TRFK5 BioLegend 500829 400x 
169Tm IL-13 JES105A2 BioLegend 504309 400x 
170Er CD3 UCHT1 Fluidigm 3170001B 100x 
171Yb CD28 CD28.2 BioLegend 302937 200x 
172Yb CD38 HIT2 Fluidigm 3172007B 200x 
173Yb CD45RO UCHL1 BioLegend 304239 100x 
175Lu CD279 (PD-1) EH 12.2H7 Fluidigm 3175008B 100x 
176Yb CD56 NCAM16.2 Fluidigm 3176008B 100x 
